A Case Report Overwhelming response to TNF-alfa inhibitor Infliximab “innovator” Vs. Adalimumab “Bio-similar” in a previously therapy naive adult. Indian Journal of Case Reports, [S. l.], v. 8, n. 3, p. 58–61, 2022. DOI: 10.32677/ijcr.v8i3.3317. Disponível em: https://mansapublishers.com/index.php/ijcr/article/view/3317.. Acesso em: 29 apr. 2025.